NO801496L - PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES - Google Patents

PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES

Info

Publication number
NO801496L
NO801496L NO801496A NO801496A NO801496L NO 801496 L NO801496 L NO 801496L NO 801496 A NO801496 A NO 801496A NO 801496 A NO801496 A NO 801496A NO 801496 L NO801496 L NO 801496L
Authority
NO
Norway
Prior art keywords
pyrazole
chlorophenyl
fluorophenyl
acetic acid
solution
Prior art date
Application number
NO801496A
Other languages
Norwegian (no)
Inventor
Helmut Biere
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO801496L publication Critical patent/NO801496L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av forbindelsene angitt i krav 11 The present invention relates to a method for producing the compounds specified in claim 11

Pyrazolderivater med den generelle formel I ifølge krav 1 er kjent fra,tysk patentansøkning P 26 33 992, men deres fremstilling ved de kjente fremgangsmåter er meget kostbar, og de erholdte utbytter er ofte utilfredsstillende. Pyrazole derivatives of the general formula I according to claim 1 are known from German patent application P 26 33 992, but their production by the known methods is very expensive, and the yields obtained are often unsatisfactory.

Ved foreliggende fremgangsmåte lykkes det derimot å fremstille pyrazdlderivatene med den generelle formel I ved en enkel syntese i gode utbytter. The present method, on the other hand, succeeds in preparing the pyrazdl derivatives of the general formula I by a simple synthesis in good yields.

Foreliggende fremgangsmåte utføres under i og for seg kjente betingelser (Org. Reactions, ^3, (1946) , 83-107; Angew. Chem., 70, (1958), 351-367 og Synthesis (1975), 358-375). The present method is carried out under conditions known per se (Org. Reactions, ^3, (1946), 83-107; Angew. Chem., 70, (1958), 351-367 and Synthesis (1975), 358-375) .

Foreliggende fremgangsmåte utføres i nærvær av primære eller sekundære aminer.. Egnede aminer er f. eks. methylamin, ethylamin, dimethylamin, diethylamin, dibutylamin, anilin, The present method is carried out in the presence of primary or secondary amines. Suitable amines are e.g. methylamine, ethylamine, dimethylamine, diethylamine, dibutylamine, aniline,

a-, 3- eller Y-Picolin'piperidin eller særlig morfolin og pyrrolidin. α-, 3- or Y-Picolin' piperidine or especially morpholine and pyrrolidine.

De følgende utførelseseksempler tjener til å belyse oppfinnelsen ytterligere. The following exemplary embodiments serve to further illustrate the invention.

Eksempel 1Example 1

a) 28,9 g 4-fluoranilin tilsettes 260 ml 15%-ig saltsyre og 260 g is, avkjøles til -5°C og diazoteres med 19,7 g a) 28.9 g of 4-fluoroaniline is added to 260 ml of 15% hydrochloric acid and 260 g of ice, cooled to -5°C and diazotized with 19.7 g

natriumnitrit i 50 ml vann. Under stadig omrøring og av-kjøling tildryppes en oppløsning av 38,4 g 3-klor-2,4-pentan-dion, 260 ml ethanol, 260 g isvann og 350 g natriumacetat-hydrat. Blandingen omrøres i ytterligere 3 timer ved 0°C, fortynnes så med vann, hvorved forbindelsen utkrystalliserer. Krystallresiduet omkrystalliseres fra ethanol, og man får 50 g 1-klor-l-(4-fluorfenylhydrazono)-2-propanon med smp. 148°C. sodium nitrite in 50 ml of water. With constant stirring and cooling, a solution of 38.4 g of 3-chloro-2,4-pentanedione, 260 ml of ethanol, 260 g of ice water and 350 g of sodium acetate hydrate is added dropwise. The mixture is stirred for a further 3 hours at 0°C, then diluted with water, whereby the compound crystallizes out. The crystal residue is recrystallized from ethanol, and 50 g of 1-chloro-1-(4-fluorophenylhydrazono)-2-propanone with m.p. 148°C.

b) En oppløsning av 19,6 g 4-brombenzylcyanid i 100 ml toluen blir ved -10°C under nitrogen tilsatt dråpevis 108 ml b) A solution of 19.6 g of 4-bromobenzyl cyanide in 100 ml of toluene is added dropwise to 108 ml at -10°C under nitrogen

av en 20%-ig oppløsning av diisobutylaluminiumhydrid (Dibah)of a 20% solution of diisobutylaluminum hydride (Dibah)

i toluen<p>g omrøres så i ytterligere 15 minutter. Efter forsiktig tilsetning av 35 ml ethanol tilsettes 250 ml vann og ca. 20 ml konsentrert svovelsyre (til pH 2), og der omrøres i 15 minutter ved 0°C. Derefter fraskilles toluenfasen, og in toluene<p>g is then stirred for a further 15 minutes. After carefully adding 35 ml of ethanol, add 250 ml of water and approx. 20 ml of concentrated sulfuric acid (to pH 2), and stir for 15 minutes at 0°C. The toluene phase is then separated, and

vannfasen efterekstraheres med toluen, de forenede toluen-oppløsninger vaskes med vann og tørres over magnesiumsulfat. Efter filtrering tilsettes toluenoppløsningen av 4-klorfényl-acetaldehyd 78 g morfolin, og der inndampes langsomt til halvt volum i vakuum og hensettes over natten. Efter inn-dampning av oppløsningen omrøres residuet med cyclohexan, hvorved krystallisasjon skjer. Krystallisatet omkrystalliseres så fra diisopropylether, og man får 12 g 4-(4-brom-styryl)-morfolin med smp. 142°C. c) En oppløsning av 7,2 g 4-(4-bromstyryl)-morfolin i 30 ml kloroform tilsettes efter hverandre med 2,7 g triethyl-amin og en oppløsning av 5,3 g 1-klor-l-(4-fluorfenylhydra-zono)-2-propanon i 30 ml kloroform og omrøres over natten ved værelsetemperatur (alternativt kan der kokes under til-bakeløp i 4 timer). Efter vasking med 2N saltsyre, natrium-hydrogencarbonatoppløsning og vann tørres kloroformfasen med magnesiumsulfat og inndampes. Det fra hexan (cyclohexan) krystalliserte residuum (10,5 g) kan enten videreopparbeides eller omkrystalliseres nok en gang fra ethanol; og man får 3-acetyl-4-(4-bromfenyl)-1-(4-fluorfenyl)-5-morfolino-4,5-dihydropyrazol med smp. 148°C. d) En oppløsning av 10 g av ovennevnte dihydropyrazol i 110 ml dioxan kokes med 30 ml 2N saltsyre i 60-90 minutter the water phase is subsequently extracted with toluene, the combined toluene solutions are washed with water and dried over magnesium sulphate. After filtration, 78 g of morpholine are added to the toluene solution of 4-chlorophenylacetaldehyde, which is slowly evaporated to half the volume in a vacuum and allowed to stand overnight. After evaporation of the solution, the residue is stirred with cyclohexane, whereby crystallization takes place. The crystallisate is then recrystallized from diisopropyl ether, and 12 g of 4-(4-bromo-styryl)-morpholine with m.p. 142°C. c) A solution of 7.2 g of 4-(4-bromostyryl)-morpholine in 30 ml of chloroform is added successively with 2.7 g of triethylamine and a solution of 5.3 g of 1-chloro-1-(4- fluorophenylhydra-zono)-2-propanone in 30 ml of chloroform and stirred overnight at room temperature (alternatively, it can be boiled under reflux for 4 hours). After washing with 2N hydrochloric acid, sodium bicarbonate solution and water, the chloroform phase is dried with magnesium sulphate and evaporated. The residue crystallized from hexane (cyclohexane) (10.5 g) can either be further worked up or recrystallized once more from ethanol; and 3-acetyl-4-(4-bromophenyl)-1-(4-fluorophenyl)-5-morpholino-4,5-dihydropyrazole is obtained with m.p. 148°C. d) A solution of 10 g of the above-mentioned dihydropyrazole in 110 ml of dioxane is boiled with 30 ml of 2N hydrochloric acid for 60-90 minutes

under tilbakeløp. Derpå inndampes i vakuum, residuet taes opp i ethylacetat, vaskes med vann, tørres med magnesiumsulfat og inndampes i vakuum. Residuet krystalliseres fra methanol, og man får 7,5 g 3-acetyl-4-(4-bromfenyl)-1-(4-fluorfenyl)-pyrazol med smp. 185°C. during reflux. It is then evaporated in vacuo, the residue is taken up in ethyl acetate, washed with water, dried with magnesium sulfate and evaporated in vacuum. The residue is crystallized from methanol, and 7.5 g of 3-acetyl-4-(4-bromophenyl)-1-(4-fluorophenyl)-pyrazole with m.p. 185°C.

e) En blanding av 7,2 g av 3-acetylpyrazol-dérivatet og 0,84 g svovel oppvarmes i 9 ml morfolin i 3-4 timer ved e) A mixture of 7.2 g of the 3-acetylpyrazole derivative and 0.84 g of sulfur is heated in 9 ml of morpholine for 3-4 hours at

135°C, helles så i 150 ml isvann og omrøres godt. Det av-sugede bunnfall krystalliseres fra ethylacetat og dioxan, og man får 7,8 g 4-[4-(4-bromfenyl)-1-(4-fluorfenyl)-3-pyrazolyl-thioacetyl]-morfolin med smp. 211°C. 135°C, then pour into 150 ml of ice water and stir well. The aspirated precipitate is crystallized from ethyl acetate and dioxane, and 7.8 g of 4-[4-(4-bromophenyl)-1-(4-fluorophenyl)-3-pyrazolyl-thioacetyl]-morpholine are obtained with m.p. 211°C.

f) En blanding av 7,4 g ifølge eksempel ld fremstilt thio-acetylmorfolinderivat i 20 ml dimethylsulfoxyd tilsettes 6,4 g f) A mixture of 7.4 g of the thio-acetylmorpholine derivative prepared according to example 1d in 20 ml of dimethylsulfoxide is added to 6.4 g

natriumhydroxyd i 30 ml vann og oppvarmes under tilbakeløp i 5 timer. Efter helling i isvann krystalliserer natriumsaltet ut, avsuges, vaskes med methylehklorid og suspenderes i 2N saltsyre. Man får 5 g 4-(4-bromfenyl)-1-(4-fluorfenyl)-3-pyråzol-eddiksyre med smp. 175°C. sodium hydroxide in 30 ml of water and heated under reflux for 5 hours. After pouring into ice water, the sodium salt crystallizes out, filtered off with suction, washed with methyl chloride and suspended in 2N hydrochloric acid. 5 g of 4-(4-bromophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid with m.p. 175°C.

Eksempel 2 Example 2

Analogt med eksempel 1 fåes 4-(4-klorfenyl)-1-(.4-fluorfenyl)-3-pyrazol-eddiksyre med smp. 148°C (ethanol/vann). Analogous to example 1, 4-(4-chlorophenyl)-1-(.4-fluorophenyl)-3-pyrazole-acetic acid is obtained with m.p. 148°C (ethanol/water).

De anvendte mellomprodukter er: 4-(4-klorstyryl)-morfolin med smp. 102°C (diisopropylether) (fremstilt analogt med eksempel lb fra 4-klorbenzyl-cyanid) The intermediates used are: 4-(4-chlorostyryl)-morpholine with m.p. 102°C (diisopropyl ether) (prepared analogously to example 1b from 4-chlorobenzyl cyanide)

3-acetyl-4-(4-klorfenyl)-1-(4-fluorfenyl)-5-morfolino-4,5-dihydropyrazol, smp. 137°C (ethanol) 3-acetyl-4-(4-chlorophenyl)-1-(4-fluorophenyl)-5-morpholino-4,5-dihydropyrazole, m.p. 137°C (ethanol)

3- acetyl-4-(4-klorfenyl)-1-(4-fluorfenyl)-pyrazol, smp. 181°C (isopropylalkohol) 4- [4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazolyl-thio-acetyl]-morfolin, smp;. 213°C (dioxan) 3- acetyl-4-(4-chlorophenyl)-1-(4-fluorophenyl)-pyrazole, m.p. 181°C (isopropyl alcohol) 4-[4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazolyl-thio-acetyl]-morpholine, m.p. 213°C (dioxane)

4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazol-eddiksyre-natriumsalt, smp. 299°C (vann). 4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid sodium salt, m.p. 299°C (water).

Fremstillingen av 3-acetyl-4-(4-klorfenyl)-1-(4-fluor-fenyl) -pyrazol kan også skje analogt med eksempel lc fra a-dimethylamino-4-klorstyren og 1-klor-l-(4-fluorfenyl-hydrazono)-propan-2-on. The production of 3-acetyl-4-(4-chlorophenyl)-1-(4-fluoro-phenyl)-pyrazole can also take place analogously to example 1c from α-dimethylamino-4-chlorostyrene and 1-chloro-1-(4- fluorophenyl-hydrazono)-propan-2-one.

Utgangsmaterialet, a-dimethylamino-4-klorstyren, kan også fåes på følgende måte: The starting material, α-dimethylamino-4-chlorostyrene, can also be obtained in the following way:

En oppløsning av 8 g 4-klorbenzylklorid i 50 ml ether tilsettes dråpevis til 1,5 g magnesiumspon (under argon) og omrøres så i 30 minutter. Derpå avkjøles oppløsningen til -15°G og tilsettes dråpevis med 11 g rent dimethylformamid og 30 ml tetrahydrofuran. Reaksjonsblandingen omrøres i 3 timer ved -15°C, inndampes så forsiktig i vakuum og tilsettes 50 ml 2N ammoniumkloridoppløsning såvel som ethylacetat. Det organ-iske residuum krystalliseres fra methanol, og man får 5 g ct-dimethylamino-4-klorstyren med smp. 77°C. Eksempel 3 A solution of 8 g of 4-chlorobenzyl chloride in 50 ml of ether is added dropwise to 1.5 g of magnesium shavings (under argon) and then stir for 30 minutes. The solution is then cooled to -15°G and 11 g of pure dimethylformamide and 30 ml of tetrahydrofuran are added dropwise. The reaction mixture is stirred for 3 hours at -15°C, then carefully evaporated in vacuo and 50 ml of 2N ammonium chloride solution as well as ethyl acetate are added. The organic residue is crystallized from methanol, and 5 g of ct-dimethylamino-4-chlorostyrene with m.p. 77°C. Example 3

Analogt med eksempel 1 fremstilles 1,4-bis-(4-klor-. fenyl)-3-pyrazol-l-eddiksyre med smp. 184°C (toluen). Analogous to example 1, 1,4-bis-(4-chloro-.phenyl)-3-pyrazole-1-acetic acid is prepared with m.p. 184°C (toluene).

De anvendte mellomprodukter er: The intermediate products used are:

1-klor-l-,(4-klorfenylhydrazono)-2-propanon,1-chloro-1-(4-chlorophenylhydrazono)-2-propanone,

smp. 175°C (ethanol) (fremstilt analogt med eksempel- la fra 4-kloranilin). m.p. 175°C (ethanol) (prepared analogously to example 1a from 4-chloroaniline).

3- acetyl-l,4-bis-(4-klorfenyl)-pyrazol, smp. 190°C 3-acetyl-1,4-bis-(4-chlorophenyl)-pyrazole, m.p. 190°C

(dioxan)(dioxane)

4- [1,4-bis-(4-klorfenyl)-3-pyrazolyl-thioacetyl]-morfolin, smp. 204°C (dioxan) 4-[1,4-bis-(4-chlorophenyl)-3-pyrazolyl-thioacetyl]-morpholine, m.p. 204°C (dioxane)

Eksempel 4Example 4

Analogt med eksempel 1 fremstilles 4-(4-klorfenyl)-1-(4-methylthiofenyl)-3-pyrazol-eddiksyre med smp. 169°C (methanol). Analogous to example 1, 4-(4-chlorophenyl)-1-(4-methylthiophenyl)-3-pyrazole-acetic acid is prepared with m.p. 169°C (methanol).

De anvendte mellomprodukter er: 1-klor-l-(4-methylthiofenylhydrazono)-2-propanon, smp. 110°C (tetraklormethan); (fremstilt analogt med eksempel la fra 4-methylthioanilin). The intermediates used are: 1-chloro-1-(4-methylthiophenylhydrazono)-2-propanone, m.p. 110°C (tetrachloromethane); (prepared analogously to example 1a from 4-methylthioaniline).

3- acetyl-4-(4-klorfenyl)-1-(4-methylthiofenyl)-pyrazol, smp. 85°C (methanol) 3- acetyl-4-(4-chlorophenyl)-1-(4-methylthiophenyl)-pyrazole, m.p. 85°C (methanol)

4- [4-(4-klorfenyl)-1-(4-methylthiofenyl)-3-pyrazolyl-thioacetyl ] -morfolin, smp. 248°C (ethylacetat) 4-[4-(4-chlorophenyl)-1-(4-methylthiophenyl)-3-pyrazolyl-thioacetyl]-morpholine, m.p. 248°C (ethyl acetate)

Eksempel 5Example 5

En oppløsning av 1,8 g 4-(4-klorfenyl)-1-(4-methylthio-fenyl)-3-pyrazol-eddiksyre (fremstilt ifølge eksempel 4) i en blanding av 20 ml kloroform og 20 ml eddiksyre tilsettes 1 ml hydrogenperoxyd (30%) og omrøres ved værelsetemperatur i A solution of 1.8 g of 4-(4-chlorophenyl)-1-(4-methylthio-phenyl)-3-pyrazole-acetic acid (prepared according to example 4) in a mixture of 20 ml of chloroform and 20 ml of acetic acid is added to 1 ml hydrogen peroxide (30%) and stirred at room temperature i

1 time. Derpå fortynnes med vann, hvorved forbindelsen 1 hour. It is then diluted with water, whereby the compound

krystalliserer ut. Den krystallinske forbindelse avsuges, vaskes med varmt vann og omkrystalliseres fra methanol, og man får 1,4 g 4-(4-klorfenyl)-1-(4-methylsulfinylfenyl)-3-pyrazol-eddiksyre med smp. 193°C. crystallizes out. The crystalline compound is filtered off, washed with hot water and recrystallized from methanol, and 1.4 g of 4-(4-chlorophenyl)-1-(4-methylsulfinylphenyl)-3-pyrazole-acetic acid with m.p. 193°C.

Eksempel 6Example 6

Analogt med eksempel 1 fremstilles 4-(4-klorfenyl)-1-fenyl-3-pyrazol-eddiksyre med smp. 169°C (toluen). Analogous to example 1, 4-(4-chlorophenyl)-1-phenyl-3-pyrazole-acetic acid is prepared with m.p. 169°C (toluene).

De anvendte mellomprodukter er: 1-klor-l-fenylhydrazono-2-propanon, smp. 136°C The intermediates used are: 1-chloro-1-phenylhydrazono-2-propanone, m.p. 136°C

(ethanol)(ethanol)

3- acetyl-4-(4-klorfenyl)-1-fenyl-pyrazol,3- acetyl-4-(4-chlorophenyl)-1-phenyl-pyrazole,

smp. 101°C (methanol) m.p. 101°C (methanol)

4- [4- (4-klorfenyl)-1-fenyl-3-pyrazblylthioacetyl]-morfolin, smp. 205°C (dioxan).. 4-[4-(4-chlorophenyl)-1-phenyl-3-pyrazblylthioacetyl]-morpholine, m.p. 205°C (dioxane)..

Eksempel 7Example 7

En oppløsning av 2 g 4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazol-eddiksyre (fremstilt ifølge eksempel 2) i 30 ml dimethylformamid tilsettes en oppløsning av 600 mg kobber(II)-acetat i 35 ml dimethylformamid og omrøres i 8 timer ved værelsetemperatur. Efter avdestillering av oppløsnings-midlet i vakuum oppløses det oljeaktige residuum i aceton, og residuet frafiltreres. Efter fordampning av acetonet krystalliseres saltresiduet fra methanol. Man får 1,7 g 4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazoleddiksyre-kobber(II)-salt-monohydrat med smp. 171°C. A solution of 2 g of 4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid (prepared according to example 2) in 30 ml of dimethylformamide is added to a solution of 600 mg of copper (II) acetate in 35 ml of dimethylformamide and stirred for 8 hours at room temperature. After distilling off the solvent in vacuum, the oily residue is dissolved in acetone, and the residue is filtered off. After evaporation of the acetone, the salt residue is crystallized from methanol. 1.7 g of 4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazoleacetic acid copper(II) salt monohydrate with m.p. 171°C.

Eksempel 8Example 8

Analogt med eksempel 1 fremstilles 1,4-bis-(4-fluor-fenyl) -3-pyrazol-eddiksyre (smp. 116°C fra tetraklormethan). Analogous to example 1, 1,4-bis-(4-fluoro-phenyl)-3-pyrazole-acetic acid (m.p. 116°C from tetrachloromethane) is prepared.

Eksempel 9Example 9

Analogt med eksempel 1 fremstilles 4-(2,4-diklorfenyl)-1-(4-f luorf enyl)-3-pyrazoleddiksyre ..(smp. 133°C fra toluen). Analogously to example 1, 4-(2,4-dichlorophenyl)-1-(4-fluorophenyl)-3-pyrazoleacetic acid is prepared (m.p. 133°C from toluene).

Eksempel 10Example 10

Analogt med eksempel 1 fremstilles 1-(2-fluorfenyl)-4-(4-nitrofenyl)-3-pyrazol-eddiksyre (smp. 208°C fra eddiksyre-ethylester). Analogous to example 1, 1-(2-fluorophenyl)-4-(4-nitrophenyl)-3-pyrazole-acetic acid is prepared (m.p. 208°C from acetic acid ethyl ester).

Eksempel 11Example 11

Analogt med eksempel 1 fremstilles 4-(4-klorfenyl)-1-(2-fluorfenyl)-3-pyrazol-eddiksyre (smp. 187°C fra eddiksyre-ethylester). Analogous to example 1, 4-(4-chlorophenyl)-1-(2-fluorophenyl)-3-pyrazole-acetic acid (m.p. 187°C from acetic acid ethyl ester) is prepared.

Eksempel 12Example 12

Analogt med eksempel 1 fremstilles 1-(4-fluorfenyl)-4-(4-nitrofenyl)-3-pyrazol-eddiksyre (smp. 254°C fra aceto- Analogously to example 1, 1-(4-fluorophenyl)-4-(4-nitrophenyl)-3-pyrazole-acetic acid (m.p. 254°C) is prepared from aceto-

4- • nitril). 4- • nitrile).

Eksempel 13Example 13

Analogt med eksempel 1 fremstilles 4-(3,4-diklorfenyl)-1-(4-fluorfenyl)-3-pyrazol-eddiksyre (smp. 178°C fra toluen). Analogous to example 1, 4-(3,4-dichlorophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid is prepared (m.p. 178°C from toluene).

Claims (1)

Fremgangsmåte ved fremstilling av pyrazolderivater med - den generelle formel: Procedure for the preparation of pyrazole derivatives with - the general formula: hvor R^ , R2, R^ og R^ er substituenter i ortho-, meta- eller, para-stilling og er hydrogen, halogen, alkyl, alkoxy, trifluormethyl, nitro, amino, alkylthio eller alkylsulfonyl, idet minst én av substituentene R.^ til R^ er forskjellig fra hydrogen,. og deres salter med fysiologisk godtagbare baser, karakterisert ved at en forbindelse med formelen: where R^ , R2, R^ and R^ are substituents in the ortho-, meta- or para-position and are hydrogen, halogen, alkyl, alkoxy, trifluoromethyl, nitro, amino, alkylthio or alkylsulfonyl, at least one of the substituents R .^ to R^ is different from hydrogen,. and their salts with physiologically acceptable bases, characterized in that a compound of the formula: hvor , . R2 , R-j og R^ er som ovenfor, angitt, omsettes mod svovel og et amin med den generelle formel: hvor R^ og Rg sammen danner en tetramethylengruppe, en penta-methylengruppe eller, en ethoxyethylengruppe, eller hvor R,, er hydrogen eller alkyl med 1 - 4 carbonatomer, og R, er alkyl med 1 - 4 carbonatomer, fenyl eller pyridyl, og at den erholdte forbindelse med den generelle formel: hvor R^ til Rg er som ovenfor angitt, hydrolyseres ved hjelp av syrer eller baser, og de erholdte syrer eventuelt over-føres til deres salter. where , . R 2 , R 1 and R 2 are, as indicated above, reacted with sulfur and an amine with the general formula: where R 2 and R 2 together form a tetramethylene group, a pentamethylene group or, an ethoxyethylene group, or where R 2 is hydrogen or alkyl with 1 - 4 carbon atoms, and R, is alkyl with 1 - 4 carbon atoms, phenyl or pyridyl, and that the obtained compound with the general formula: where R^ to Rg are as indicated above, is hydrolysed with the aid of acids or bases, and the acids obtained are optionally transferred to their salts.
NO801496A 1979-05-21 1980-05-20 PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES NO801496L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792920941 DE2920941A1 (en) 1979-05-21 1979-05-21 3-Pyrazole-acetic acid deriv. prepn. - by reacting 3-acetyl-pyrazole deriv. with sulphur and amine and hydrolysing the pyrazolyl-thio-acetyl deriv.

Publications (1)

Publication Number Publication Date
NO801496L true NO801496L (en) 1980-11-24

Family

ID=6071550

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801496A NO801496L (en) 1979-05-21 1980-05-20 PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES

Country Status (6)

Country Link
DE (1) DE2920941A1 (en)
DK (1) DK151626C (en)
FI (1) FI77655C (en)
GR (1) GR68455B (en)
HU (1) HU185383B (en)
NO (1) NO801496L (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE748539C (en) * 1941-01-16 1944-11-06 Process for the preparation of the amides of heterocyclically substituted acetic acids or the free acids

Also Published As

Publication number Publication date
DK219180A (en) 1980-11-22
DK151626B (en) 1987-12-21
FI77655B (en) 1988-12-30
GR68455B (en) 1981-12-30
HU185383B (en) 1985-01-28
FI801639A (en) 1980-11-22
DE2920941A1 (en) 1980-11-27
DK151626C (en) 1988-07-18
FI77655C (en) 1989-04-10

Similar Documents

Publication Publication Date Title
SU649312A3 (en) Method of obtaining 4-(polyalkoxyphenyl)-2-pyrrolidones
CA2101521A1 (en) 5-heteroyl indole derivatives
SE452610B (en) SETTING DIVERSE RACEMIC CIS-1,2-CYCLOPROPANDICARBOXYLIC ACID DERIVATIVES
SK286143B6 (en) Process for preparing mesylates of piperazine derivatives and compounds prepared in such a manner
HU197881B (en) Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
CN112390725B (en) Preparation method of amide compound
US4820847A (en) Process for the preparation of 4-substituted 1-aryl-5-amino-pyrazoles
JP6256484B2 (en) Method for producing pyridazine compound
EP2118058B1 (en) Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
JP6251197B2 (en) Process for preparing substituted phenylpropanones
NO801496L (en) PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES
US4200759A (en) Preparation of imidazo[2,1-a]isoindole compounds
US4864032A (en) Process for the preparation of indazoles
HU196955B (en) Process for producing substituted phenyl-hydrazine derivatives
JPH01197472A (en) Production of 5-amino-1-phenyl-4-nitropyrazoles
CS219280B2 (en) Method of making the pyrazol derivatives
JP2021526142A (en) Process for preparing 2- (1- (tert-butoxycarbonyl) piperidine-4-yl) benzoic acid
CN111807997A (en) Synthesis method of N- (4-methoxycarbonyl-3-aminosulfonylbenzyl) methanesulfonamide
JPS63192748A (en) Manufacture of 2-cyano-2-oxyiminoacetamide
CH616659A5 (en)
NO139479B (en) PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DIHALOGEN-PHENYL-ETHANOLAMINES
CA2456531C (en) Process for the preparation of 4-(imidazole-1-yl)benzenesulfonamide derivatives
WO2002060861A1 (en) Benzamidine derivatives and process for production thereof
EP0036684A1 (en) Derivatives of 4-methyl-5-(2-aminoethyl)-thiomethyl-imidazole having therapeutic activity
US4977274A (en) 4-hydroxyindole derivatives, the process for preparation thereof and their use